Skip to main navigation Skip to search Skip to main content

Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.

Translated title of the contribution: Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.
  • M.S. van der Veer
  • , M. de Weers
  • , B. van Kessel - Welmers
  • , J.M. Bakker
  • , S. Wittebol
  • , P.W.H.I. Parren
  • , H.M. Lokhorst
  • , T. Mutis

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionTowards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.
Original languageUndefined/Unknown
Pages (from-to)284-290
Number of pages7
JournalHaematologica
Volume96
Issue number2
Publication statusPublished - 2011

Cite this